Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV Update for the quarter ended 31 March 2011

23 May 2011 10:00

RNS Number : 0765H
Greenwich Loan Income Fund Ltd
23 May 2011
 



23 May 2011

 

Greenwich Loan Income Fund Limited

 

NAV Update for the quarter ended 31 March 2011

 

Greenwich Loan Income Fund Limited ("GLIF" or "the Company") announces that as at 31 March 2011, its unaudited net asset value (NAV) per share was 70.3p. This compares to the final reported NAV of 79.2p per share as at 31 December 2010.

 

The weighted average market bid for the Company's investment portfolio at the quarter end was 95.5% of par, and for the liabilities, 85.2%. This compares to last quarter's figures of 93.4% of par and 82.2% respectively. The change in NAV resulted from the issuance of shares below NAV per share in connection with the acquisition of AMIC PLC, as well as the somewhat larger upward movement in the fair value of liabilities compared to portfolio assets. There was also a slight offset to these factors resulting from the modest strengthening of the GBP against the US dollar from year-end to 31 March.

 

As previously described to shareholders, under International Financial Reporting Standards (IFRS), the consolidated results of operations for the Company include the impact of carrying its investments and its liabilities at fair value. Shareholders should be aware that the Company's realisation of the full NAV is unlikely. The NAV, as calculated in accordance with IFRS, reflects the theoretical fair value of the liabilities of the CLO but, because the market is rather illiquid, it may be difficult for the Company to acquire any or a significant portion of those liabilities.

 

It should also be noted, as announced on 27 April 2011, that the Company is reviewing its exposure to T2 CLO I Ltd ("the CLO"), and were the CLO to no longer be consolidated in the future, the Company would carry its interest in CLO paper at fair value as determined by the Board of Directors. The Company expects that the resultant carrying value would be less than the proportionate share of NAV represented by the retained CLO interest as currently calculated under IFRS because it would no longer reflect the marking to market of liabilities below par. As a result, the net asset value determined post-deconsolidation of the CLO should be more comparable to other listed loan-focused investment companies.

 

The other two values customarily calculated to provide further clarity as to the dynamics within the value of the business are as follows:

 

- the value based upon assets at market value and liabilities at par was 50.2p per share as at 31 March 2011, compared to 45.4p per share as at 31 December 2010.

 

- the value based upon CLO assets as calculated for interest diversion purposes, remaining assets at market, and liabilities at par was 54.0p per share as at 31 March 2011, compared to 52.8p as at 31 December 2010.

 

The portfolio statistics on the Company's website (www.glifund.com) have been updated to include the most recent quarter. The CLO portfolio continues to increase in credit quality (as measured by the weighted average rating test) over the past year, whilst the weighted average spread (not taking into account LIBOR floors) has also increased. One major trend within the portfolio has been the increasing level of prepayments, averaging approximately 10% per quarter for the past year. During this period, the Company's investment manager has been able to deploy the capital successfully and in a manner consistent with the Company's investment objectives.

 

 

Contacts:

 

Geoffrey Miller

Greenwich Loan Income Fund Limited

+353 1 4433 466

 

Patrick Conroy

Greenwich Loan Income Fund Limited

+1 203 983 5282

 

Philip Secrett

Nominated Adviser

Grant Thornton Corporate Finance

+44 207 383 5100

 

James Maxwell

Singer Capital Markets Limited

+44 (0) 20 3205 7622

 

Ed Gascoigne Pees

Financial Dynamics

+44 (0) 207 269 7132

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVGIGDUCSDBGBX
Date   Source Headline
18th Sep 20137:00 amRNSAdditional Listing
2nd Sep 20137:00 amRNSInvestment in crowd-funding platform
16th Aug 20134:15 pmRNSHolding(s) in Company
25th Jul 20137:58 amRNSNAV and Trading Update
25th Jul 20137:58 amRNSDividend Declaration
16th Jul 20137:00 amRNSInvestment
17th Jun 20137:00 amRNSDirector/PDMR Shareholding
14th Jun 20137:00 amRNSAdditional Listing
10th Jun 201311:00 amRNSShare Dealing
6th Jun 20134:00 pmRNSDirector/PDMR Shareholding
24th May 20135:00 pmRNSDirector/PDMR Shareholding
22nd May 20138:00 amRNSDirector/PDMR Shareholding
17th May 20139:00 amRNSDirector/PDMR Shareholding
15th May 20138:20 amRNSDirector/PDMR Shareholding
14th May 20134:30 pmRNSDirector/PDMR Shareholding
13th May 20138:00 amRNSHolding(s) in Company
30th Apr 20134:00 pmRNSResult of AGM
25th Apr 20138:30 amRNSHolding(s) in Company
23rd Apr 20134:45 pmRNSDirector/PDMR Shareholding
22nd Apr 20133:15 pmRNSHolding(s) in Company
18th Apr 20138:15 amRNSDividend Declaration
18th Apr 20138:15 amRNSNAV Update and CLO Test Result
9th Apr 20135:30 pmRNSAnnual Report
3rd Apr 20137:00 amRNSFull Year Results 2012
28th Mar 20137:02 amRNSNotice of Preliminary Results
23rd Jan 20137:01 amRNSPlacing
23rd Jan 20137:00 amRNSNAV Update, dividend payment and CLO Test Results
18th Jan 20132:49 pmRNSDirector/PDMR Shareholding
19th Nov 20122:30 pmRNSHolding(s) in Company
14th Nov 201212:00 pmRNSHolding(s) in Company
13th Nov 20128:00 amRNSHolding(s) in Company
12th Nov 201212:30 pmRNSDirector/PDMR Shareholding
8th Nov 201212:45 pmRNSConfirmation of Final Consideration Payable
7th Nov 20127:00 amRNSAcquisition
29th Oct 20127:00 amRNSAnnouncement of Dividend
19th Oct 20127:00 amRNSNAV Update and Quarterly CLO Test Results
20th Sep 20127:00 amRNSHalf Year Results 2012 Replacement
18th Sep 20126:27 pmRNSDirector/PDMR Shareholding
14th Sep 20127:00 amRNSHalf Year Results 2012
19th Jul 20129:00 amRNSTrading Statement
17th Jul 20123:51 pmRNSHolding(s) in Company
30th Apr 20125:00 pmRNSResult of AGM
20th Apr 20129:30 amRNSQuarterly CLO Test Results
19th Apr 20125:00 pmRNSNAV Update and dividend
5th Apr 20127:00 amRNSAnnual Financial Report
30th Mar 20122:46 pmRNSDealing by Investment Manager
26th Mar 20127:00 amRNSFull Year Results 2011
13th Mar 20127:00 amRNSNotice of Results
12th Mar 20127:00 amRNSChange of Adviser
19th Jan 20124:50 pmRNSNAV Update and Dividend Payment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.